BACKGROUND: The use of brain natriuretic peptide (BNP) in the evaluation of the dyspneic pediatric patient is increasingly supported for infants and newborns with congenital heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback